Simvastatin and indomethacin have similar anti-inflammatory activity in a rat model of acute local inflammation

Basic and Clinical Pharmacology and Toxicology

Volumn 104, Issue 3, 2009, Pages 185-191

  Nežić, Lana ^a   Škrbić, Ranko ^a   Dobrić, Silva ^b   Stojiljković, Miloš P ^c   Jaćević, Vesna ^b   Šatara, Svjetlana Stoisavljević ^a   Milovanović, Zoran A ^b   Stojaković, Nataša ^a  

^a UNIVERSITY OF BANJA LUKA   (Bosnia and Herzegovina)

^b UNIVERSITY OF DEFENCE   (Serbia)

^c UNIVERSITY OF EAST SARAJEVO   (Bosnia and Herzegovina)

Author keywords

[No Author keywords available]

Indexed keywords

CARRAGEENAN; INDOMETACIN; METHYLCELLULOSE; SIMVASTATIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CELL INFILTRATION; CONTROLLED STUDY; DISEASE SEVERITY; DOSE RESPONSE; DRUG EFFICACY; DRUG INHIBITION; FOOT PAD; HISTOPATHOLOGY; INFLAMMATION; MALE; NEUTROPHIL; NONHUMAN; PAW EDEMA; PLETHYSMOGRAPH; PRIORITY JOURNAL; RAT; SKIN BIOPSY; TISSUE INJURY; WISTAR RAT;

ADMINISTRATION, ORAL; ANIMALS; ANTI-INFLAMMATORY AGENTS; CARRAGEENAN; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; EDEMA; INDOMETHACIN; INFLAMMATION; MALE; NEUTROPHIL INFILTRATION; RATS; RATS, WISTAR; SIMVASTATIN;

ANIMALIA; RATTUS;

EID: 60349087903     PISSN: 17427835     EISSN: 17427843     Source Type: Journal    
DOI: 10.1111/j.1742-7843.2008.00302.x     Document Type: Article

References (48)

1. Scandinavian Simvastatin Survival Study. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the survival study group. Lancet 1994 344 : 1383 9.
2. Zhou Z, Rahme E, Pilote L. Are statins created equal? Evidence from randomized trials of pravastatin, simvastatin, and atorvastatin for cardiovascular disease prevention. Am Heart J 2006 151 : 273 81.
3. Ford I, Murray H, Packard CJ, Shepherd J, Macfarlane PW, Cobbe SM, the West of Scotland Coronary Prevention Study Group. Long-term follow-up of the West of Scotland Coronary Prevention Study. N Engl J Med 2007 357 : 1477 86.
4. John S, Schneider MP, Delles C, Jacobi J, Schmieder RE. Lipid-independent effects of statins on endothelial function and bioavailability of nitric oxide in hypercholesterolemic patients. Am Heart J 2005 149 : 473.
5. Sanguigni V, Pignatelli P, Lenti L, Ferro D, Bellia A, Carnevale R et al. Short-term treatment with atorvastatin reduces platelet CD40 ligand and thrombin generation in hypercholesterolemic patients. Circulation 2005 111 : 412 9.
6. Rutishauser J. The role of statins in clinical medicine-LDL-cholesterol lowering and beyond. Swiss Med Wkly 2006 136 : 41 9.
7. Son JW, Koh KK, Ahn JY, Jin DK, Park GS, Kim DS et al. Effects of statin on plaque stability and thrombogenicity in hypercholesterolemic patients with coronary artery disease. Int J Cardiol 2003 88 : 77 82.
8. März W, Köenig W. HMG-CoA reductase inhibition: anti-inflammatory effects beyond lipid lowering? J Cardiovasc Risk 2003 10 : 169 79.
9. Ross R. Atherosclerosis: an inflammatory disease. N Engl J Med 1999 340 : 115 26.
10. Seasholtz TM, Brown JH. RHO signaling in vascular diseases. Mol Interv 2004 4 : 348 57.
11. Devaraj S, Chan E, Jialal I. Direct demonstration of an antiinflammatory effect of simvastatin in subjects with the metabolic syndrome. J Clin Endocrinol Metab 2006 91 : 4489 96.
12. Steiner S, Speidl WS, Pleiner J, Seidinger D, Zorn G, Kaun C et al. Simvastatin blunts endotoxin-induced tissue factor in vivo. Circulation 2005 111 : 1841 6.
13. Pleiner J, Schaller G, Mittermayer F, Zorn S, Marsik C, Polterauer S et al. Simvastatin prevents vascular hyporeactivity during inflammation. Circulation 2004 110 : 3349 54.
14. Pruefer D, Makowski J, Schnell M, Buerke U, Dahm M, Oelert H et al. Simvastatin inhibits inflammatory properties of Staphylococcus aureus alpha-toxin. Circulation 2002 106 : 2104 10.
15. Rezaie-Majd A, Maca T, Bucek RA, Valent P, Müller MR, Husslein P et al. Simvastatin reduces expression of cytokines interleukin-6, interleukin-8, and monocyte chemoattractant protein-1 in circulating monocytes from hypercholesterolemic patients. Arterioscler Thromb Vasc Biol 2002 22 : 1194 9.
16. Winter CA, Risley EA, Nuss GW. Carrageenin-induced edema in hind paw of the rat as an assay for anti-inflammatory drugs. Proc Soc Exp Biol Med 1962 11 : 544 7.
17. Pinheiro RM, Calixto JB. Effect of the selective COX-2 inhibitors, celecoxib and rofecoxib in rat acute models of inflammation. Inflamm Res 2002 51 : 603 10.
18. Petrović SD, Dobrić S, Bokonjić D, Niketić M, Garcia-Pineres A, Merfort I. Evaluation of Tanacetum larvatum for an anti-inflammatory activity and for the protection against indomethacin-induced ulcerogenesis in rats. J Ethnopharmacol 2003 87 : 109 13.
19. Kundaković T, Fokialakis N, Dobrić S, Pratsinis H, Kletsas D, Kovačević N et al. Evaluation of the anti-inflammatory and cytotoxic activities of naphthazarine derivatives from Onosma leptantha. Phytomedicine 2006 13 : 290 4.
20. Abdel-Salam OM, Baiuomy AR, Arbid MS. Studies on the anti-inflammatory effect of fluoxetine in the rat. Pharmacol Res 2004 49 : 119 31.
21. Halici Z, Dengiz GO, Odabasoglu F, Suleyman H, Cadirci E, Halici M. Amiodarone has anti-inflammatory and anti-oxidative properties: an experimental study in rats with carrageenan-induced paw edema. Eur J Pharmacol 2007 566 : 215 21.
22. Sparrow CP, Burton CA, Hernandez M, Mundt S, Hassing H, Patel S et al. Simvastatin has anti-inflammatory and antiatherosclerotic activities independent of plasma cholesterol lowering. Arterioscler Thromb Vasc Biol 2001 21 : 115 21.
23. Ni W, Egashira K, Kataoka C, Kitamoto S, Koyanagi M, Inoue S et al. Anti-inflammatory and antiarteriosclerotic actions of HMG-CoA reductase inhibitors in a rat model of chronic inhibition of nitric oxide synthesis. Circ Res 2001 89 : 415 21.
24. Leung, BP, Sattar N, Crilly A, Prach M, McCarey DW, Payne H et al. A novel anti-inflammatory role for simvastatin in inflammatory arthritis. J Immunol 2003 170 : 1524 30.
25. Litchfield JT, Wilcoxon FA. A simplified method of evaluating dose-effect experiments. J Pharmacol Exp Ther 1949 96 : 99 113.
26. Di Rosa M, Giroud JP, Willoughby DA. Studies of the mediators of the acute inflammatory response induced in rats in different sites by carrageenan and turpentine. J Pathol 1971 104 : 15 29.
27. Pinheiro RM, Calixto JB. Effect of the selective COX-2 inhibitors, celecoxib and rofecoxib in rat acute models of inflammation. Inflamm Res 2002 51 : 603 10.
28. Francischi JN, Chaves CT, Moura AC, Lima AS, Rocha OA, Ferreira-Alves DL et al. Selective inhibitors of cyclo-oxygenase-2 (COX-2) induce hypoalgesia in a rat paw model of inflammation. Br J Pharmacol 2002 137 : 837 44.
29. Miceli N, Taviano MF, Giuffrida D, Trovato A, Tzakou O, Galati EM. Anti-inflammatory activity of extract and fractions from Nepeta sibthorpii Bentham. J Ethnopharmacol 2005 97 : 261 6.
30. Suleyman H, Gul HI, Gul M, Alkan M, Gocer F. Anti-inflammatory activity of bis(3-aryl-3-oxo-popyl) methylamine hydrochloride in rat. Biol Pharm Bull 2007 30 : 63 7.
31. Salvemini D, Wang ZQ, Bourdon DM, Stern MK, Currie MG, Manning PT. Evidence of peroxynitrite involvement in the carrageenan-induced rat paw oedema. Eur J Pharmacol 1996 303 : 217 20.
32. Boughton-Smith NK, Deakin AM, Follenfant RL, Whittle BJR, Coarland LG. Role of oxygen radicals and arachidonic acid metabolites in the reverse passive arthus reaction and carrageenan paw oedema in the rat. Br J Pharmacol 1999 110 : 896 902.
33. Nacife VP, Soeiro MN, Gomes RN, D'Avila H, Castro-Faria NHC, Meirelles MN. Morphological and biochemical characterization of macrophages activated by carrageenan and lipopolysaccharide in vivo. Cell Struct Funct 2004 29 : 27 34.
34. Marzocco S, Di Paola R, Serraino I, Sorrentino R, Meli R, Mattaceraso G et al. Effect of methylguanidine in carrageenan-induced acute inflammation in the rats. Eur J Pharmacol 2004 484 : 341 50.
35. Diomede L, Albani D, Sottocorno M, Polentarutti N, Donati MB, Bianchi M et al. The in vivo anti-inflammatory effect of statins is mediated by nonsterol mevalonate products. Arterioscler Thromb Vasc Biol 2001 21 : 1327 32.
36. Landsberger M, Wolff B, Jantzen F, Rosenstengel C, Vogelgesang D, Staudt A et al. Cerivastatin reduces cytokine-induced surface expression of ICAM-1 via increased shedding in human endothelial cells. Atherosclerosis 2007 190 : 43 52.
37. Laufs U, La Fata V, Plutzky J, Liao JK. Upregulation of endothelial nitric oxide synthase by HMG-CoA reductase inhibitors. Circulation 1998 1129 35.
38. Scalia R, Gooszen ME, Jones SP, Hoffmeyer M, Rimmer DM, Trocha SD et al. Simvastatin exerts both anti-inflammatory and cardioprotective effects in apolipoprotein E-deficient mice. Circulation 2001 103 : 2598 603.
39. Stalker TJ, Lefer AM, Scalia R. A new HMG-CoA reductase inhibitor, rosuvastatin, exerts anti-inflammatory effects on the microvascular endothelium: the role of mevalonic acid. Br J Pharmacol 2001 133 : 406 12.
40. Veillard NR, Braunersreuther V, Arnaud C, Burger F, Pelli G, Steffens S et al. Simvastatin modulates chemokine and chemokine receptor expression by geranylgeranyl isoprenoid pathway in human endothelial cells and macrophages. Atherosclerosis 2006 188 : 51 8.
41. Xu H, Liu P, Liang L, Danesh FR, Yang X, Ye Y et al. RhoA-mediated, tumor necrosis factor alpha-induced activation of NF-kappaB in rheumatoid synoviocytes: inhibitory effect of simvastatin. Arthritis Rheum 2006 54 : 3441 51.
42. Habib A, Shamseddeen I, Nasrallah MS, Antoun TA, Nemer G, Bertoglio J et al. Modulation of COX-2 expression by statins in human monocytic cells. FASEB J 2007 21 : 1665 74.
43. Bandoh T, Sato EF, Mitani H, Nakashima A, Hoshi K, Inoue M. Antioxidative potential of fluvastatin via the inhibition of nicotinamide adenine dinucleotide phosphate (NADPH) oxidase activity. Biol Pharm Bull 2003 26 : 818 22.
44. Weitz-Schmidt G, Welzenbach K, Brinkmann V, Kamata T, Kallen J, Bruns C et al. Statins selectively inhibit leukocyte function antigen-1 by binding to a novel regulatory integrin site. Nat Med 2001 7 : 687 92.
45. Weitz-Schmidt G, Welzenbach K, Dawson J, Kallen J. Improved lymphocyte function-associated antigen-1 (LFA-1) inhibition by statin derivatives: molecular basis determined by x-ray analysis and monitoring of LFA-1 conformational changes in vitro and ex vivo. Biol Chem 2004 279 : 46764 71.
46. McKay A, Leung BP, McInnes IB, Thomson NC, Liew FY. A novel anti-inflammatory role of simvastatin in a murine model of allergic asthma. J Immunol 2004 172 : 2903 8.
47. Abeles AM, Pillinger MH. Statins as antiinflammatory and immunomodulatory agents: a future in rheumatologic therapy? Arthritis Rheum 2006 54 : 393 407.
48. Paumelle R, Blanquart C, Briand O, Barbier O, Duhem C, Woerly G et al. Acute antiinflammatory properties of statins involve peroxisome proliferator-activated receptor-alpha via inhibition of the protein kinase C signaling pathway. Circ Res 2006 98 : 361 9.